e-learning
resources
ERJ
2015
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Blood stem cell transplantation to treat cystic lung light chain deposition disease
Borgne Aurélie Le, Prévot Grégoire, Rouquette Isabelle, Huynh Anne, Têtu Laurent, Projetti Fabrice, Carreiro Miguel, Borie Raphaël, Jaccard Arnaud, Recher Christian, Didier Alain
Source:
Eur Respir J 2015; 46: 1199-1202
Journal Issue:
October
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Borgne Aurélie Le, Prévot Grégoire, Rouquette Isabelle, Huynh Anne, Têtu Laurent, Projetti Fabrice, Carreiro Miguel, Borie Raphaël, Jaccard Arnaud, Recher Christian, Didier Alain. Blood stem cell transplantation to treat cystic lung light chain deposition disease. Eur Respir J 2015; 46: 1199-1202
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Stem cell therapy in cystic fibrosis
Mesenchymal stem cell therapy for severe emphysema
Mesenchymal stem cell therapy for severe emphysema
Related content which might interest you:
Noninfectious infiltrative lung diseases after allogeneic hematopoïetic stem cell transplantation (HSCT)
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013
Restrictive chronic lung function decline after haematopoietic stem cell transplantation
Source: Eur Respir J 2016; 47: 336-339
Year: 2016
Lung stem cells and therapy for cystic fibrosis
Source: Eur Respir Monogr 2021; 91: 306-321
Year: 2021
Pretransplant lung function tests in patients with malignant hemopathy undergoing stem cell transplantation.
Source: Virtual Congress 2021 – What's new in respiratory problems in rare and systemic diseases
Year: 2021
Pulmonary veno-occlusive disease after hematopoietic stem cell transplantation
Source: International Congress 2015 – Interstitial lung diseases I
Year: 2015
Early lung function alterations after allogeneic hematopoietic stem cell transplantation
Source: Annual Congress 2010 - Mechanisms and modulation of allergic inflammation in the lung
Year: 2010
Treating systemic sclerosis with lung involvement: from observation to stem cell transplantation
Source: International Congress 2018 – Respiratory medicine meets rheumatology
Year: 2018
Multiple breath washout can facilitate the diagnosis of lung graft-versus-host disease in children after allogeneic hematopoietic stem cell transplantation
Source: International Congress 2016 – Insights into the pathophysiology of childhood lung disease
Year: 2016
Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury
Source: Eur Respir J 2009; 34: 740
Year: 2009
Pulmonary infiltrates in allogenic hematopoietic stem cell transplantation recipients
Source: Eur Respir J 2002; 20: Suppl. 38, 476s
Year: 2002
Noninfectious lung complications after allogeneic haematopoietic stem cell transplantation
Source: Eur Respir J, 51 (5) 1702617; 10.1183/13993003.02617-2017
Year: 2018
Lung function improvement after hematopoetic stem cell transplantation
Source: Eur Respir J 2007; 30: Suppl. 51, 173s
Year: 2007
Noninfectious pulmonary complications of haematopoietic stem cell transplantation
Source: Eur Respir Rev, 29 (156) 190119; 10.1183/16000617.0119-2019
Year: 2020
Mesenchymal stem cell therapy reduces inflammation and damage in a model of chronic lung disease
Source: ERS Lung Science Conference 2017
Year: 2017
Primary airway epithelial cell culture from lung transplant recipients
Source: Eur Respir J 2005; 26: 1080-1085
Year: 2005
Small airways function declines after allogeneic haematopoietic stem cell transplantation
Source: Eur Respir J 2011; 38: 1180-1188
Year: 2011
Effects of bone marrow mesenchymal stem cells on bleomycin induced pulmonary fibrosis in rats
Source: Annual Congress 2006 - Pulmonary fibrosis: pathophysiology and therapeutic approaches
Year: 2006
Small airways function in allogeneic hematopoietic stem cell transplant recipients worsens over time and is correlated with change in chronic GVHD grade
Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases
Year: 2011
Lung function prior to stem cell transplant as a predictor of infectious and pulmonary complications and survival in adults with haematologic malignancies
Source: International Congress 2015 – Prognostic factors in pneumonia: from clinical observations to experimental models
Year: 2015
Progress towards human lung regeneration in end-stage respiratory failure: studying human lung development in vitro using organoid cultures of human embryonic lung stem cells
Source: International Congress 2018 – Cell-matrix interactions in lung disease and regeneration
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept